hotspot -WSS

hotspot

author：knowledge 2025-09-30 00:45:06 - browse：191

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

WSS

Eat, drink, but be wary — 4 foods that interact with medications

Tuberculosis patients need more than just free medication

Paxlovid rebound happens. Why and to whom are still a mystery

Paxlovid rebound happens. Why and to whom are still a mystery

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Failure, not just success, should guide future doctors

hotspot

hotspot

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Google's generative AI to analyze medical images — and talk to docs

After affirmative action ruling, medical educators look to 'holistic review'

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Prosecutors seek bail revocation for FTX founder Sam Bankman

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medical mystery: When an infection after surgery isn’t what it seems

Medicare details structure of new drug price negotiation program

Medical mystery: When an infection after surgery isn’t what it seems

Wikipedia

Slovenia has suffered its worst

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Russian court extends detention of American musician

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Doctors push to include dialysis machines in emergency stockpile

knowledge

hotspot

focus

explore